Tackling preventable healthcare associated infections, such as MRSA bloodstream infections, is one of the Government’s key priorities. With around a sixth of trusts reporting zero cases of MRSA bloodstream infection over the past year, a point has been reached where preventable MRSA bloodstream infections should no longer be acceptable in NHS funded services.
The NHS planning guidance explains that in the case of an MRSA bloodstream infection, a post infection review will identify why an infection occurred and how future cases can be avoided.
MRSA screening guidance (England) update
The Department of Health advisory committee on Antimicrobial Resistance and Healthcare Associated Infections (ARHAI) have published new guidance outlining a more focused, cost-effective approach to MRSA screening whilst concentrating on reducing infections and improving patient health.
These new guidelines have been informed by the National One Week (NOW) study and could be used to inform policy making decisions should the prevalence of MRSA increase.